Cargando…

Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1(G93A) ALS mouse model

Amyotrophic lateral sclerosis (ALS) is an untreatable, progressive, neurodegenerative disease specifically affecting motor neurons. Recently, the tyrosine kinase receptor EphA4 was directly implicated in ALS disease progression. We report that a long-lived mutated form of the EphA4 antagonist EphA4-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, J., Cooper, L. T., Boyd, A. W., Bartlett, P. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065374/ https://www.ncbi.nlm.nih.gov/pubmed/30061574 http://dx.doi.org/10.1038/s41598-018-29845-1

Ejemplares similares

Inducible EphA4 knockout causes motor deficits in young mice and is not protective in the SOD1(G93A) mouse model of ALS
por: Dominguez, Sara L., et al.
Publicado: (2020)

Role of EphA4 in Mediating Motor Neuron Death in MND
por: Zhao, Jing, et al.
Publicado: (2021)

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

Resveratrol Ameliorates Motor Neuron Degeneration and Improves Survival in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Song, Lin, et al.
Publicado: (2014)

Verapamil Ameliorates Motor Neuron Degeneration and Improves Lifespan in the SOD1(G93A) Mouse Model of ALS by Enhancing Autophagic Flux
por: Zhang, Xiaojie, et al.
Publicado: (2019)

Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1(G93A)) of ALS
por: Chiarotto, Gabriela Bortolança, et al.
Publicado: (2019)

Retracted: Resveratrol Ameliorates Motor Neuron Degeneration and Improves Survival in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: BioMed Research International,
Publicado: (2019)

A closer look at the SOD1(G93Adl) mouse model of ALS
Publicado: (2011)

Characterization of somatosensory neuron involvement in the SOD1(G93A) mouse model
por: Rubio, Miguel A., et al.
Publicado: (2022)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Influence of Methylene Blue on Microglia-Induced Inflammation and Motor Neuron Degeneration in the SOD1(G93A) Model for ALS
por: Dibaj, Payam, et al.
Publicado: (2012)

Glycoengineering of EphA4 Fc leads to a unique, long-acting and broad spectrum, Eph receptor therapeutic antagonist
por: Pegg, Cassandra L., et al.
Publicado: (2017)

Calretinin and Neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1(G93A) mouse model of ALS
por: Clark, Rosemary M., et al.
Publicado: (2017)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival
por: Herath, N I, et al.
Publicado: (2009)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Microglia Morphological Changes in the Motor Cortex of hSOD1(G93A) Transgenic ALS Mice
por: Migliarini, Sara, et al.
Publicado: (2021)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

Tempol Moderately Extends Survival in a hSOD1(G93A) ALS Rat Model by Inhibiting Neuronal Cell Loss, Oxidative Damage and Levels of Non-Native hSOD1(G93A) Forms
por: Linares, Edlaine, et al.
Publicado: (2013)

Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis
por: Peters, Owen M, et al.
Publicado: (2018)

Impact of Pharmacological Inhibition of Hydrogen Sulphide Production in the SOD1G93A-ALS Mouse Model
por: Spalloni, Alida, et al.
Publicado: (2019)

Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice
por: Marc, Gotkine, et al.
Publicado: (2013)

Alterations in AQP4 expression and polarization in the course of motor neuron degeneration in SOD1G93A mice
por: Dai, Jiaying, et al.
Publicado: (2017)

MPO/HOCl Facilitates Apoptosis and Ferroptosis in the SOD1(G93A) Motor Neuron of Amyotrophic Lateral Sclerosis
por: Peng, Jialing, et al.
Publicado: (2022)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

NU-9 improves health of hSOD1(G93A) mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
por: Genç, Barış, et al.
Publicado: (2022)

Genetic Biomarkers for ALS Disease in Transgenic SOD1(G93A) Mice
por: Calvo, Ana C., et al.
Publicado: (2012)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
por: Shin, Jae Min, et al.
Publicado: (2023)

Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis
por: Lee, John D., et al.
Publicado: (2019)

Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods
por: Vinsant, Sharon, et al.
Publicado: (2013)

Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion
por: Vinsant, Sharon, et al.
Publicado: (2013)

Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
por: Yan, Lina, et al.
Publicado: (2018)

Time Course of Alterations in Adult Spinal Motoneuron Properties in the SOD1(G93A) Mouse Model of ALS
por: Huh, Seoan, et al.
Publicado: (2021)

Locus-specific analysis of Transposable Elements during the progression of ALS in the SOD1(G93A) mouse model
por: Valdebenito-Maturana, Braulio, et al.
Publicado: (2021)

Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1(G93A) ALS mouse model
por: Zhang, Haoyun, et al.
Publicado: (2022)

A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS
por: Rogers, Christopher Q., et al.
Publicado: (2023)

Corrigendum to “Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice”
por: Gotkine, Marc, et al.
Publicado: (2015)

Compensatory Motor Neuron Response to Chromatolysis in the Murine hSOD1(G93A) Model of Amyotrophic Lateral Sclerosis
por: Riancho, Javier, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q14fs9kto1febnhpt6tmbajo5o